![Combined burden and functional impact tests for cancer driver discovery using DriverPower | Nature Communications Combined burden and functional impact tests for cancer driver discovery using DriverPower | Nature Communications](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41467-019-13929-1/MediaObjects/41467_2019_13929_Fig1_HTML.png)
Combined burden and functional impact tests for cancer driver discovery using DriverPower | Nature Communications
![Frontiers | Partners in Crime: Beta-Cells and Autoimmune Responses Complicit in Type 1 Diabetes Pathogenesis Frontiers | Partners in Crime: Beta-Cells and Autoimmune Responses Complicit in Type 1 Diabetes Pathogenesis](https://www.frontiersin.org/files/Articles/756548/fimmu-12-756548-HTML-r1/image_m/fimmu-12-756548-g001.jpg)
Frontiers | Partners in Crime: Beta-Cells and Autoimmune Responses Complicit in Type 1 Diabetes Pathogenesis
![Salomon Driver Prime Sigma Plus - Black - M (56-59 cm) Wir sind Ihr Spezialist für Outdoor , wintersport. hockey und mehr. Salomon Driver Prime Sigma Plus - Black - M (56-59 cm) Wir sind Ihr Spezialist für Outdoor , wintersport. hockey und mehr.](https://www.twinseasons.de/resize/l47010900e6a9a35848145e2e1c4ec55001ad38cc-ts_17563763839954.jpg/0/1100/True/salomon-driver-prime-sigma-plus-black.jpg)
Salomon Driver Prime Sigma Plus - Black - M (56-59 cm) Wir sind Ihr Spezialist für Outdoor , wintersport. hockey und mehr.
![Profiling the Mismatch Tolerance of Argonaute 2 through Deep Sequencing of Sliced Polymorphic Viral RNAs: Molecular Therapy - Nucleic Acids Profiling the Mismatch Tolerance of Argonaute 2 through Deep Sequencing of Sliced Polymorphic Viral RNAs: Molecular Therapy - Nucleic Acids](https://www.cell.com/cms/attachment/13bf2545-09b7-4665-913c-2cc54b3af349/fx1_lrg.jpg)
Profiling the Mismatch Tolerance of Argonaute 2 through Deep Sequencing of Sliced Polymorphic Viral RNAs: Molecular Therapy - Nucleic Acids
![A computational method for prioritizing targeted therapies in precision oncology: performance analysis in the SHIVA01 trial | npj Precision Oncology A computational method for prioritizing targeted therapies in precision oncology: performance analysis in the SHIVA01 trial | npj Precision Oncology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41698-021-00191-2/MediaObjects/41698_2021_191_Fig1_HTML.png)